Hrain Biotechnology Co., Ltd.

Privately held: no public share price

Assets

(4 total)
4Total Assets
0Approved
0Phase 3 / Filed
4Phase 1–2 / Early
2Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
Phase 2
BCMACell therapy
Multiple Myeloma
Phase 2
BCMACell therapy
Multiple Myeloma
Phase 1
FLT3Cell therapy
Acute Myeloid Leukemia
Phase 1
BCMACell therapy
Multiple Myeloma

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.